About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

The 12th Beijing Xiangshan Forum opened this morning at the Beijing International Convention Center. Defense Minister Dong Jun attended the opening ceremony and delivered a speech. The forum's theme was "Jointly Safeguarding the International Order a

2025-09-18

The 12th Beijing Xiangshan Forum opened this morning at the Beijing International Convention Center. Defense Minister Dong Jun attended the opening ceremony and delivered a speech. The forum's theme was "Jointly Safeguarding the International Order and Promoting Peaceful Development." Over 100 countries, regions, and international organizations participated, with approximately 1,800 registered delegates, observers, and journalists attending.

Other News
2025-09-18

Novo Nordisk (NVO.N): The 25 mg oral version of semaglutide showed improvements in the ability to perform daily physical activities and cardiovascular risk factors. The safety and tolerability profile of oral semaglutide was consistent with that of W

Novo Nordisk (NVO.N): The 25 mg oral version of semaglutide showed improvements in the ability to perform daily physical activities and cardiovascular risk factors. The safety and tolerability profile of oral semaglutide was consistent with that of Wegovy for injection.
2025-09-18

US President Trump: Taking the next step after reaching a historic agreement in the field of science.

US President Trump: Taking the next step after reaching a historic agreement in the field of science.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2025 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.

Web Design by YSD